Literature DB >> 25353705

Reliability, validity, and responsiveness of the Impact of Weight on Self-Perceptions Questionnaire (IW-SP) in individuals with type 2 diabetes and obesity.

Risa P Hayes1, Amy M DeLozier.   

Abstract

BACKGROUND: The Impact of Weight on Self-Perceptions Questionnaire (IW-SP) assesses an individual's self-perception related to his or her weight. The primary objective of this study was to provide evidence of the reliability, validity, and responsiveness of the IW-SP.
MATERIALS AND METHODS: Study participants were individuals with type 2 diabetes mellitus (T2DM) and obesity enrolled in clinical weight-loss programs in the United States. Data were obtained for clinical measures, IW-SP, and other patient-reported outcome measures. An intraclass correlation coefficient (ICC) and Cronbach's α were calculated for test-retest reliability and internal consistency, respectively. For validity, correlations and t tests were performed. For responsiveness, baseline and 6-month data for a subgroup of patients were analyzed using the paired t test and calculation of effect size (ES).
RESULTS: Reliability data for 106 study participants (mean age, 52 years; 69% female; 31% white; mean body mass index, 38 kg/m(2)) yielded an ICC of 0.85 and Cronbach's α values of >0.89. IW-SP scores were associated with obesity-related quality of life, mental health, and vitality (r>0.50, P<0.001). In the subgroup (n=40) used to estimate responsiveness, weight was significantly less at end point than at baseline (mean, baseline=231.9 vs. end point=222.0 pounds; P<0.001; ES=0.23), and IW-SP scores were significantly better than at baseline (mean, baseline=61.0 vs. end point=72.1 [on a scale of 0-100]; P=0.01; ES=0.34). Mean IW-SP change scores significantly discriminated between those achieving >5% body weight loss and those who achieved <5% (mean change, 23.6 vs. 5.7; P=0.03).
CONCLUSIONS: The IW-SP has demonstrated reliability, validity, and responsiveness in individuals with T2DM and obesity, thereby making it a potentially valuable tool in the evaluation of weight-loss interventions targeted toward patients with T2DM.

Entities:  

Mesh:

Year:  2014        PMID: 25353705     DOI: 10.1089/dia.2014.0142

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  3 in total

1.  Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi Arabia.

Authors:  Heather L Gelhorn; Kristina S Boye; Huda Shalhoub; Louis S Matza; Jessica B Jordan; Ali Alhammad; Savita B Anand; Aishah A Ekhzaimy; Alena Strizek
Journal:  Patient Prefer Adherence       Date:  2020-11-10       Impact factor: 2.711

2.  Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review.

Authors:  Priscilla Jia Ling Wee; Yu Heng Kwan; Dionne Hui Fang Loh; Jie Kie Phang; Troy H Puar; Truls Østbye; Julian Thumboo; Sungwon Yoon; Lian Leng Low
Journal:  J Med Internet Res       Date:  2021-08-13       Impact factor: 5.428

3.  The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics.

Authors:  Luis-Emilio García-Pérez; Kristina S Boye; Myriam Rosilio; Heike Jung; Elke Heitmann; Kirsi Norrbacka; Marco Orsini Federici; Raffaella Gentilella; Bruno Guerci; Francesco Giorgino; Ulrich Aigner; Hélène Sapin
Journal:  Diabetes Ther       Date:  2021-06-07       Impact factor: 2.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.